Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …

In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …

Rationale: In recent decades, diagnosis and treatment recommendations for idiopathic
pulmonary fibrosis (IPF) have changed. In Korea, the average life expectancy has increased …

Background Patients with idiopathic pulmonary fibrosis (IPF) frequently have multiple
comorbidities, which may influence survival but go under-recognised in clinical practice. We …

Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established
to better understand its natural history, though their size and duration of follow-up are …

Introduction Recent developments in the care of patients with idiopathic pulmonary fibrosis
have the potential to improve survival rates. Population-based estimates of the current …

The prevalence of idiopathic pulmonary fibrosis (IPF), a fatal and progressive lung disease,
is estimated at 1.25–63 out of 100 000, making large population studies difficult. Recently …

There is no debate that idiopathic pulmonary fibrosis (IPF) is a devastating disease that has
a significant impact on patient morbidity and mortality. Patients with IPF experience …

As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a
need to coordinate data on incidence and mortality globally. This study aims to …

Background: Real-world data regarding outcomes of idiopathic pulmonary fibrosis (IPF) are
scarce, outside of registries. The claims data from the French National Health System …